Image pharmaphorum Editor News FDA 'playbook' aims to prevent hacking of medical devices The FDA has unveiled new guidance outlining how healthcare organisations can prepare their medical devices and staff in the event of a security breach. News Roche buys Tusk, plus cancer immunotherapy drug, for £62m Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million. News US regulator backs Pfizer's Vizimpro lung cancer drug The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation. News Australians still concerned as My Health Record row continue... The controversial Australian data scheme, My Health Record, continues to spark mixed reactions and uncertainty from professionals and the public. Load more results
News FDA 'playbook' aims to prevent hacking of medical devices The FDA has unveiled new guidance outlining how healthcare organisations can prepare their medical devices and staff in the event of a security breach.
News Roche buys Tusk, plus cancer immunotherapy drug, for £62m Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.
News US regulator backs Pfizer's Vizimpro lung cancer drug The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation.
News Australians still concerned as My Health Record row continue... The controversial Australian data scheme, My Health Record, continues to spark mixed reactions and uncertainty from professionals and the public.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.